English

GLOBEIMMUNE INC

EDGAR

GBIM Quarterly report (10-Q) · filed 2016-05-12

13 filing records in this dataset, filed from 2012-07-02 to 2016-05-12. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

943 thousand USD

2016 Q1 · USD

Exact inputs and evidence

Revenue: 942750 USD Source

Operating cash flow

-1.21 million USD

2016 Q1 · USD

Exact inputs and evidence

Operating Cash Flow: -1207004 USD Source

Cash and cash equivalents: 8.69 million USD 2016-03-31 Source
Exact value

8693718 USD
Long-term debt including current maturities: Not available
Shares outstanding: 5.75 million shares 2016-03-31 Source
Exact value

5751574 shares

Reported share-count change

0.00% · 0 shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

5751574 shares · 2015-03-31· Source
5751574 shares · 2016-03-31· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

6.21 million USD

2015-04-01 – 2016-03-31

Exact inputs and evidence

Revenue: 1277047 USD · 2015-04-01 – 2015-06-30 Source
Revenue: 2944947 USD · 2015-07-01 – 2015-09-30 Source
Revenue: 6457733 USD · 2015-01-01 – 2015-12-31 Source
Revenue: 5409819 USD · 2015-01-01 – 2015-09-30 Source
Revenue: 942750 USD · 2016-01-01 – 2016-03-31 Source

Net income

-2.07 million USD

2015-04-01 – 2016-03-31

Exact inputs and evidence

Net income: -1304947 USD · 2015-04-01 – 2015-06-30 Source
Net income: 893602 USD · 2015-07-01 – 2015-09-30 Source
Net income: -2766905 USD · 2015-01-01 – 2015-12-31 Source
Net income: -1971873 USD · 2015-01-01 – 2015-09-30 Source
Net income: -862208 USD · 2016-01-01 – 2016-03-31 Source

Operating cash flow

-5.9 million USD

2015-04-01 – 2016-03-31

Exact inputs and evidence

Operating cash flow: -4413024 USD · 2015-01-01 – 2015-06-30 Source
Operating cash flow: -2431807 USD · 2015-01-01 – 2015-03-31 Source
Operating cash flow: -5721201 USD · 2015-01-01 – 2015-09-30 Source
Operating cash flow: -4413024 USD · 2015-01-01 – 2015-06-30 Source
Operating cash flow: -7129697 USD · 2015-01-01 – 2015-12-31 Source
Operating cash flow: -5721201 USD · 2015-01-01 – 2015-09-30 Source
Operating cash flow: -1207004 USD · 2016-01-01 – 2016-03-31 Source

Capital expenditure

35.7 thousand USD

2015-01-01 – 2015-12-31

Exact inputs and evidence

Capital expenditure: 23937 USD · 2015-01-01 – 2015-03-31 Source
Capital expenditure: 34148 USD · 2015-01-01 – 2015-06-30 Source
Capital expenditure: 23937 USD · 2015-01-01 – 2015-03-31 Source
Capital expenditure: 35742 USD · 2015-01-01 – 2015-09-30 Source
Capital expenditure: 34148 USD · 2015-01-01 – 2015-06-30 Source
Capital expenditure: 35742 USD · 2015-01-01 – 2015-12-31 Source
Capital expenditure: 35742 USD · 2015-01-01 – 2015-09-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2016-05-12.

Financial data available through: 2015-12-31.

Coverage by financial measure

Revenue: 4 of 11 periods available· newest 2015-12-31
Operating income: 4 of 11 periods available· newest 2015-12-31
Net income: 4 of 11 periods available· newest 2015-12-31
Operating cash flow: 4 of 11 periods available· newest 2015-12-31
Capital expenditure: 4 of 11 periods available· newest 2015-12-31
Total assets: 3 of 11 periods available· newest 2015-12-31
Total liabilities: 3 of 11 periods available· newest 2015-12-31
Current assets: 3 of 11 periods available· newest 2015-12-31
Current liabilities: 3 of 11 periods available· newest 2015-12-31
Cash and cash equivalents: 4 of 11 periods available· newest 2015-12-31
long term debt: No compatible figures in this window
Shares outstanding: 3 of 11 periods available· newest 2015-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+8.2%

Prior period

USD 5.97 million

2014-01-01 – 2014-12-31
Current period

USD 6.46 million

2015-01-01 – 2015-12-31

Exact inputs and evidence

6457733 − 5966381 = 491352 USD

5966381 USD · 2014-01-01 – 2014-12-31
Inspect prior input Prior source
6457733 USD · 2015-01-01 – 2015-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · GLOBEIMMUNE INC · 2015-12-31 GLOBEIMMUNE INC (edgar:1245104) Year-over-year change in Revenue: 491352 USD Concept: fundies:Revenue Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-03T17:46:16Z Snapshot: f73c8d9241eb54224d81f2fab47a6b8cc458ce63f7ed531705f5c814583b9709 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1245104?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 6457733 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1245104/000156459016014874/gbim-20151231.xml#160088 Filing: 000156459016014874 Input fundies:Revenue: 5966381 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1245104/000156459016014874/gbim-20151231.xml#160229 Filing: 000156459016014874
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 13.49 million

Prior period

−USD 16.26 million

2014-01-01 – 2014-12-31
Current period

−USD 2.77 million

2015-01-01 – 2015-12-31

Exact inputs and evidence

-2766905 − -16260926 = 13494021 USD

-16260926 USD · 2014-01-01 – 2014-12-31
Inspect prior input Prior source
-2766905 USD · 2015-01-01 – 2015-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · GLOBEIMMUNE INC · 2015-12-31 GLOBEIMMUNE INC (edgar:1245104) Year-over-year change in Net income: 13494021 USD Concept: fundies:NetIncome Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-03T17:46:16Z Snapshot: f73c8d9241eb54224d81f2fab47a6b8cc458ce63f7ed531705f5c814583b9709 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1245104?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -2766905 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1245104/000156459016014874/gbim-20151231.xml#167291 Filing: 000156459016014874 Input fundies:NetIncome: -16260926 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1245104/000156459016014874/gbim-20151231.xml#167443 Filing: 000156459016014874
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 2.92 million

Prior period

−USD 10.05 million

2014-01-01 – 2014-12-31
Current period

−USD 7.13 million

2015-01-01 – 2015-12-31

Exact inputs and evidence

-7129697 − -10051096 = 2921399 USD

-10051096 USD · 2014-01-01 – 2014-12-31
Inspect prior input Prior source
-7129697 USD · 2015-01-01 – 2015-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · GLOBEIMMUNE INC · 2015-12-31 GLOBEIMMUNE INC (edgar:1245104) Year-over-year change in Operating cash flow: 2921399 USD Concept: fundies:OperatingCashFlow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-03T17:46:16Z Snapshot: f73c8d9241eb54224d81f2fab47a6b8cc458ce63f7ed531705f5c814583b9709 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1245104?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -7129697 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1245104/000156459016014874/gbim-20151231.xml#195171 Filing: 000156459016014874 Input fundies:OperatingCashFlow: -10051096 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1245104/000156459016014874/gbim-20151231.xml#195421 Filing: 000156459016014874
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-87.9%

Prior period

USD 294,200

2014-01-01 – 2014-12-31
Current period

USD 35,742

2015-01-01 – 2015-12-31

Exact inputs and evidence

35742 − 294200 = -258458 USD

294200 USD · 2014-01-01 – 2014-12-31
Inspect prior input Prior source
35742 USD · 2015-01-01 – 2015-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · GLOBEIMMUNE INC · 2015-12-31 GLOBEIMMUNE INC (edgar:1245104) Year-over-year change in Capital expenditure: -258458 USD Concept: fundies:CapitalExpenditure Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-03T17:46:16Z Snapshot: f73c8d9241eb54224d81f2fab47a6b8cc458ce63f7ed531705f5c814583b9709 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1245104?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 35742 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1245104/000156459016014874/gbim-20151231.xml#195921 Filing: 000156459016014874 Input fundies:CapitalExpenditure: 294200 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1245104/000156459016014874/gbim-20151231.xml#196128 Filing: 000156459016014874
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2015 2015-01-01 – 2015-12-31

Revenue USD 6.46 million 100% of revenue
Operating costs Derived USD 9.22 million 143% of revenue
Operating income −USD 2.77 million −43% of revenue
Tax, interest and other Derived USD 0 0% of revenue
Net income −USD 2.77 million −43% of revenue

Cash

Operating cash flow −USD 7.13 million −110% of revenue
Capital expenditure USD 35,742 0.6% of revenue
Free cash flow Derived −USD 7.17 million −111% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2012 Operating loss: operating costs were 127% of revenue.
2013 Net income was higher than operating income, so the split is not drawn.
2014 Operating loss: operating costs were 198% of revenue.
2015 Operating loss: operating costs were 143% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2012 2012-01-01 – 2012-12-31	14641606	18608090 Derived	-3966484	-1951740 Derived	-2014744	-13176868 Derived	Source 2012-01-01 – 2012-12-31: 14641606 USD Inspect Revenue Open source 2012-01-01 – 2012-12-31: -3966484 USD Inspect Operating Income Open source 2012-01-01 – 2012-12-31: -2014744 USD Inspect Net Income Open source 2012-01-01 – 2012-12-31: -13068040 USD Inspect Operating Cash Flow Open source 2012-01-01 – 2012-12-31: 108828 USD Inspect Capital Expenditure Open source
2013 2013-01-01 – 2013-12-31	22518369	14830677 Derived	7687692	-1789007 Derived	9476699	3919493 Derived	Source 2013-01-01 – 2013-12-31: 22518369 USD Inspect Revenue Open source 2013-01-01 – 2013-12-31: 7687692 USD Inspect Operating Income Open source 2013-01-01 – 2013-12-31: 9476699 USD Inspect Net Income Open source 2013-01-01 – 2013-12-31: 3931727 USD Inspect Operating Cash Flow Open source 2013-01-01 – 2013-12-31: 12234 USD Inspect Capital Expenditure Open source
2014 2014-01-01 – 2014-12-31	5966381	11785499 Derived	-5819118	10441808 Derived	-16260926	-10345296 Derived	Source 2014-01-01 – 2014-12-31: 5966381 USD Inspect Revenue Open source 2014-01-01 – 2014-12-31: -5819118 USD Inspect Operating Income Open source 2014-01-01 – 2014-12-31: -16260926 USD Inspect Net Income Open source 2014-01-01 – 2014-12-31: -10051096 USD Inspect Operating Cash Flow Open source 2014-01-01 – 2014-12-31: 294200 USD Inspect Capital Expenditure Open source
2015 2015-01-01 – 2015-12-31	6457733	9224638 Derived	-2766905	0 Derived	-2766905	-7165439 Derived	Source 2015-01-01 – 2015-12-31: 6457733 USD Inspect Revenue Open source 2015-01-01 – 2015-12-31: -2766905 USD Inspect Operating Income Open source 2015-01-01 – 2015-12-31: -2766905 USD Inspect Net Income Open source 2015-01-01 – 2015-12-31: -7129697 USD Inspect Operating Cash Flow Open source 2015-01-01 – 2015-12-31: 35742 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 6.5M 2015

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20122012-12-31	Revenue	14641606	Revenue: 14641606 Open source
20132013-12-31	Revenue	22518369	Revenue: 22518369 Open source
20142014-12-31	Revenue	5966381	Revenue: 5966381 Open source
20152015-12-31	Revenue	6457733	Revenue: 6457733 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

8.2% 2015

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20122012-12-31	Year over year	No prior comparable period	Revenue: 14641606 Open source
20132013-12-31	Year over year	53.8%	Revenue: 22518369 Open source Revenue: 14641606 Open source
20142014-12-31	Year over year	-73.5%	Revenue: 5966381 Open source Revenue: 22518369 Open source
20152015-12-31	Year over year	8.2%	Revenue: 6457733 Open source Revenue: 5966381 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -42.8% 2015

Net margin -42.8% 2015

Free cash flow margin -111% 2015

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20122012-12-31	Operating margin	-27.1%	Operating Income: -3966484 Open source Revenue: 14641606 Open source
20132013-12-31	Operating margin	34.1%	Operating Income: 7687692 Open source Revenue: 22518369 Open source
20142014-12-31	Operating margin	-97.5%	Operating Income: -5819118 Open source Revenue: 5966381 Open source
20152015-12-31	Operating margin	-42.8%	Operating Income: -2766905 Open source Revenue: 6457733 Open source
20122012-12-31	Net margin	-13.8%	Net Income: -2014744 Open source Revenue: 14641606 Open source
20132013-12-31	Net margin	42.1%	Net Income: 9476699 Open source Revenue: 22518369 Open source
20142014-12-31	Net margin	-272.5%	Net Income: -16260926 Open source Revenue: 5966381 Open source
20152015-12-31	Net margin	-42.8%	Net Income: -2766905 Open source Revenue: 6457733 Open source
20122012-12-31	Free cash flow margin	-90%	Revenue: 14641606 Open source Operating Cash Flow: -13068040 Open source Capital Expenditure: 108828 Open source
20132013-12-31	Free cash flow margin	17.4%	Revenue: 22518369 Open source Operating Cash Flow: 3931727 Open source Capital Expenditure: 12234 Open source
20142014-12-31	Free cash flow margin	-173.4%	Revenue: 5966381 Open source Operating Cash Flow: -10051096 Open source Capital Expenditure: 294200 Open source
20152015-12-31	Free cash flow margin	-111%	Revenue: 6457733 Open source Operating Cash Flow: -7129697 Open source Capital Expenditure: 35742 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -7.1M 2015

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20122012-12-31	Operating cash flow	-13068040	Operating Cash Flow: -13068040 Open source
20132013-12-31	Operating cash flow	3931727	Operating Cash Flow: 3931727 Open source
20142014-12-31	Operating cash flow	-10051096	Operating Cash Flow: -10051096 Open source
20152015-12-31	Operating cash flow	-7129697	Operating Cash Flow: -7129697 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -7.2M 2015

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20122012-12-31	Free cash flow	-13176868	Operating Cash Flow: -13068040 Open source Capital Expenditure: 108828 Open source
20132013-12-31	Free cash flow	3919493	Operating Cash Flow: 3931727 Open source Capital Expenditure: 12234 Open source
20142014-12-31	Free cash flow	-10345296	Operating Cash Flow: -10051096 Open source Capital Expenditure: 294200 Open source
20152015-12-31	Free cash flow	-7165439	Operating Cash Flow: -7129697 Open source Capital Expenditure: 35742 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

74% 2015

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2012-12-31	Liabilities / assets	Not reported	No source recorded
20132013-12-31	Liabilities / assets	256.9%	Total Liabilities: 19057383 Open source Total Assets: 7417939 Open source
20142014-12-31	Liabilities / assets	69.5%	Total Liabilities: 12764628 Open source Total Assets: 18368119 Open source
20152015-12-31	Liabilities / assets	74%	Total Liabilities: 8517741 Open source Total Assets: 11506141 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

2.62× 2015

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
2012-12-31	Current assets / current liabilities	Not reported	No source recorded
20132013-12-31	Current assets / current liabilities	1.06×	Current Assets: 6825137 Open source Current Liabilities: 6414495 Open source
20142014-12-31	Current assets / current liabilities	3.44×	Current Assets: 17812351 Open source Current Liabilities: 5172489 Open source
20152015-12-31	Current assets / current liabilities	2.62×	Current Assets: 11090775 Open source Current Liabilities: 4225439 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2012 2012-01-01 – 2012-12-31	−USD 2.01 million Exact value Exact value: -2014744 USD 2012-01-01 – 2012-12-31: -2014744 USD Inspect Net Income Open source Share or cite Citation for Net Income · GLOBEIMMUNE INC · 2012-12-31 GLOBEIMMUNE INC (edgar:1245104) Net Income: -2014744 USD Concept: fundies:NetIncome Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-03T17:46:16Z Snapshot: f73c8d9241eb54224d81f2fab47a6b8cc458ce63f7ed531705f5c814583b9709 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1245104/explain?concept=fundies%3ANetIncome&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:NetIncome: -2014744 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1245104/000156459015001755/gbim-20141231.xml#210546 Filing: 000156459015001755 The citation records this snapshot. The page link may show a newer release later.	−USD 13.07 million Exact value Exact value: -13068040 USD 2012-01-01 – 2012-12-31: -13068040 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · GLOBEIMMUNE INC · 2012-12-31 GLOBEIMMUNE INC (edgar:1245104) Operating Cash Flow: -13068040 USD Concept: fundies:OperatingCashFlow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-03T17:46:16Z Snapshot: f73c8d9241eb54224d81f2fab47a6b8cc458ce63f7ed531705f5c814583b9709 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1245104/explain?concept=fundies%3AOperatingCashFlow&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -13068040 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1245104/000156459015001755/gbim-20141231.xml#241652 Filing: 000156459015001755 The citation records this snapshot. The page link may show a newer release later.	USD 108,828 Exact value Exact value: 108828 USD 2012-01-01 – 2012-12-31: 108828 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · GLOBEIMMUNE INC · 2012-12-31 GLOBEIMMUNE INC (edgar:1245104) Capital Expenditure: 108828 USD Concept: fundies:CapitalExpenditure Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-03T17:46:16Z Snapshot: f73c8d9241eb54224d81f2fab47a6b8cc458ce63f7ed531705f5c814583b9709 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1245104/explain?concept=fundies%3ACapitalExpenditure&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 108828 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1245104/000156459015001755/gbim-20141231.xml#242318 Filing: 000156459015001755 The citation records this snapshot. The page link may show a newer release later.	−USD 13.18 million Calculation and evidence -13068040 − 108828 USD Exact free cash flow: -13176868 USD 2012-01-01 – 2012-12-31: -13068040 USD · Inspect Operating Cash Flow · Source 2012-01-01 – 2012-12-31: 108828 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · GLOBEIMMUNE INC · 2012-12-31 GLOBEIMMUNE INC (edgar:1245104) Free cash flow: -13176868 USD Concept: free-cash-flow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-03T17:46:16Z Snapshot: f73c8d9241eb54224d81f2fab47a6b8cc458ce63f7ed531705f5c814583b9709 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1245104?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -13068040 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1245104/000156459015001755/gbim-20141231.xml#241652 Filing: 000156459015001755 Input fundies:CapitalExpenditure: 108828 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1245104/000156459015001755/gbim-20141231.xml#242318 Filing: 000156459015001755 The citation records this snapshot. The page link may show a newer release later.
2013 2013-01-01 – 2013-12-31	USD 9.48 million Exact value Exact value: 9476699 USD 2013-01-01 – 2013-12-31: 9476699 USD Inspect Net Income Open source Share or cite Citation for Net Income · GLOBEIMMUNE INC · 2013-12-31 GLOBEIMMUNE INC (edgar:1245104) Net Income: 9476699 USD Concept: fundies:NetIncome Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-03T17:46:16Z Snapshot: f73c8d9241eb54224d81f2fab47a6b8cc458ce63f7ed531705f5c814583b9709 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1245104/explain?concept=fundies%3ANetIncome&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:NetIncome: 9476699 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1245104/000156459016014874/gbim-20151231.xml#167596 Filing: 000156459016014874 The citation records this snapshot. The page link may show a newer release later.	USD 3.93 million Exact value Exact value: 3931727 USD 2013-01-01 – 2013-12-31: 3931727 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · GLOBEIMMUNE INC · 2013-12-31 GLOBEIMMUNE INC (edgar:1245104) Operating Cash Flow: 3931727 USD Concept: fundies:OperatingCashFlow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-03T17:46:16Z Snapshot: f73c8d9241eb54224d81f2fab47a6b8cc458ce63f7ed531705f5c814583b9709 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1245104/explain?concept=fundies%3AOperatingCashFlow&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 3931727 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1245104/000156459016014874/gbim-20151231.xml#195672 Filing: 000156459016014874 The citation records this snapshot. The page link may show a newer release later.	USD 12,234 Exact value Exact value: 12234 USD 2013-01-01 – 2013-12-31: 12234 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · GLOBEIMMUNE INC · 2013-12-31 GLOBEIMMUNE INC (edgar:1245104) Capital Expenditure: 12234 USD Concept: fundies:CapitalExpenditure Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-03T17:46:16Z Snapshot: f73c8d9241eb54224d81f2fab47a6b8cc458ce63f7ed531705f5c814583b9709 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1245104/explain?concept=fundies%3ACapitalExpenditure&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 12234 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1245104/000156459016014874/gbim-20151231.xml#196336 Filing: 000156459016014874 The citation records this snapshot. The page link may show a newer release later.	USD 3.92 million Calculation and evidence 3931727 − 12234 USD Exact free cash flow: 3919493 USD 2013-01-01 – 2013-12-31: 3931727 USD · Inspect Operating Cash Flow · Source 2013-01-01 – 2013-12-31: 12234 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · GLOBEIMMUNE INC · 2013-12-31 GLOBEIMMUNE INC (edgar:1245104) Free cash flow: 3919493 USD Concept: free-cash-flow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-03T17:46:16Z Snapshot: f73c8d9241eb54224d81f2fab47a6b8cc458ce63f7ed531705f5c814583b9709 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1245104?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 3931727 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1245104/000156459016014874/gbim-20151231.xml#195672 Filing: 000156459016014874 Input fundies:CapitalExpenditure: 12234 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1245104/000156459016014874/gbim-20151231.xml#196336 Filing: 000156459016014874 The citation records this snapshot. The page link may show a newer release later.
2014 2014-01-01 – 2014-12-31	−USD 16.26 million Exact value Exact value: -16260926 USD 2014-01-01 – 2014-12-31: -16260926 USD Inspect Net Income Open source Share or cite Citation for Net Income · GLOBEIMMUNE INC · 2014-12-31 GLOBEIMMUNE INC (edgar:1245104) Net Income: -16260926 USD Concept: fundies:NetIncome Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-03T17:46:16Z Snapshot: f73c8d9241eb54224d81f2fab47a6b8cc458ce63f7ed531705f5c814583b9709 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1245104/explain?concept=fundies%3ANetIncome&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:NetIncome: -16260926 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1245104/000156459016014874/gbim-20151231.xml#167443 Filing: 000156459016014874 The citation records this snapshot. The page link may show a newer release later.	−USD 10.05 million Exact value Exact value: -10051096 USD 2014-01-01 – 2014-12-31: -10051096 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · GLOBEIMMUNE INC · 2014-12-31 GLOBEIMMUNE INC (edgar:1245104) Operating Cash Flow: -10051096 USD Concept: fundies:OperatingCashFlow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-03T17:46:16Z Snapshot: f73c8d9241eb54224d81f2fab47a6b8cc458ce63f7ed531705f5c814583b9709 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1245104/explain?concept=fundies%3AOperatingCashFlow&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -10051096 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1245104/000156459016014874/gbim-20151231.xml#195421 Filing: 000156459016014874 The citation records this snapshot. The page link may show a newer release later.	USD 294,200 Exact value Exact value: 294200 USD 2014-01-01 – 2014-12-31: 294200 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · GLOBEIMMUNE INC · 2014-12-31 GLOBEIMMUNE INC (edgar:1245104) Capital Expenditure: 294200 USD Concept: fundies:CapitalExpenditure Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-03T17:46:16Z Snapshot: f73c8d9241eb54224d81f2fab47a6b8cc458ce63f7ed531705f5c814583b9709 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1245104/explain?concept=fundies%3ACapitalExpenditure&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 294200 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1245104/000156459016014874/gbim-20151231.xml#196128 Filing: 000156459016014874 The citation records this snapshot. The page link may show a newer release later.	−USD 10.35 million Calculation and evidence -10051096 − 294200 USD Exact free cash flow: -10345296 USD 2014-01-01 – 2014-12-31: -10051096 USD · Inspect Operating Cash Flow · Source 2014-01-01 – 2014-12-31: 294200 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · GLOBEIMMUNE INC · 2014-12-31 GLOBEIMMUNE INC (edgar:1245104) Free cash flow: -10345296 USD Concept: free-cash-flow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-03T17:46:16Z Snapshot: f73c8d9241eb54224d81f2fab47a6b8cc458ce63f7ed531705f5c814583b9709 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1245104?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -10051096 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1245104/000156459016014874/gbim-20151231.xml#195421 Filing: 000156459016014874 Input fundies:CapitalExpenditure: 294200 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1245104/000156459016014874/gbim-20151231.xml#196128 Filing: 000156459016014874 The citation records this snapshot. The page link may show a newer release later.
2015 2015-01-01 – 2015-12-31	−USD 2.77 million Exact value Exact value: -2766905 USD 2015-01-01 – 2015-12-31: -2766905 USD Inspect Net Income Open source Share or cite Citation for Net Income · GLOBEIMMUNE INC · 2015-12-31 GLOBEIMMUNE INC (edgar:1245104) Net Income: -2766905 USD Concept: fundies:NetIncome Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-03T17:46:16Z Snapshot: f73c8d9241eb54224d81f2fab47a6b8cc458ce63f7ed531705f5c814583b9709 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1245104/explain?concept=fundies%3ANetIncome&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:NetIncome: -2766905 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1245104/000156459016014874/gbim-20151231.xml#167291 Filing: 000156459016014874 The citation records this snapshot. The page link may show a newer release later.	−USD 7.13 million Exact value Exact value: -7129697 USD 2015-01-01 – 2015-12-31: -7129697 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · GLOBEIMMUNE INC · 2015-12-31 GLOBEIMMUNE INC (edgar:1245104) Operating Cash Flow: -7129697 USD Concept: fundies:OperatingCashFlow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-03T17:46:16Z Snapshot: f73c8d9241eb54224d81f2fab47a6b8cc458ce63f7ed531705f5c814583b9709 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1245104/explain?concept=fundies%3AOperatingCashFlow&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -7129697 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1245104/000156459016014874/gbim-20151231.xml#195171 Filing: 000156459016014874 The citation records this snapshot. The page link may show a newer release later.	USD 35,742 Exact value Exact value: 35742 USD 2015-01-01 – 2015-12-31: 35742 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · GLOBEIMMUNE INC · 2015-12-31 GLOBEIMMUNE INC (edgar:1245104) Capital Expenditure: 35742 USD Concept: fundies:CapitalExpenditure Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-03T17:46:16Z Snapshot: f73c8d9241eb54224d81f2fab47a6b8cc458ce63f7ed531705f5c814583b9709 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1245104/explain?concept=fundies%3ACapitalExpenditure&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 35742 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1245104/000156459016014874/gbim-20151231.xml#195921 Filing: 000156459016014874 The citation records this snapshot. The page link may show a newer release later.	−USD 7.17 million Calculation and evidence -7129697 − 35742 USD Exact free cash flow: -7165439 USD 2015-01-01 – 2015-12-31: -7129697 USD · Inspect Operating Cash Flow · Source 2015-01-01 – 2015-12-31: 35742 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · GLOBEIMMUNE INC · 2015-12-31 GLOBEIMMUNE INC (edgar:1245104) Free cash flow: -7165439 USD Concept: free-cash-flow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-03T17:46:16Z Snapshot: f73c8d9241eb54224d81f2fab47a6b8cc458ce63f7ed531705f5c814583b9709 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1245104?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -7129697 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1245104/000156459016014874/gbim-20151231.xml#195171 Filing: 000156459016014874 Input fundies:CapitalExpenditure: 35742 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1245104/000156459016014874/gbim-20151231.xml#195921 Filing: 000156459016014874 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

13 filings · 566 latest values · 566 originally reported values

Dataset published 2026-11-03. Source filing dates and reporting periods are shown separately.

Identifiers: 0001245104, 1245104, GBIM, edgar:1245104

Also known as GLOBEIMMUNE INC

GLOBEIMMUNE INC

Latest quarter

Revenue

Operating cash flow

Reported share-count change

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2015 2015-01-01 – 2015-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation